Cleared Traditional

K843712 - AUDIT TM V

K843712 is an FDA 510(k) clearance for AUDIT TM V, manufactured by Axonics, Inc.. The device is a Class 2 Neurology device with product code GWF cleared through the Traditional 510(k) pathway after a 196-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1985
Decision
196d
Days
Class 2
Risk

K843712 is an FDA 510(k) clearance for the AUDIT TM V. Classified as Stimulator, Electrical, Evoked Response (product code GWF), Class II - Special Controls.

Submitted by Axonics, Inc. (Mountain View, US). The FDA issued a Cleared decision on April 5, 1985 after a review of 196 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1870 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K843712

510(k) Number K843712 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 1984
Decision Date April 05, 1985
Days to Decision 196 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d slower than avg
Panel avg: 149d · This submission: 196d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWF Device Classification - Class 2, Special Controls

Product Code GWF Stimulator, Electrical, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1870
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWF Stimulator, Electrical, Evoked Response

All 140
Devices cleared under the same product code (GWF) and FDA review panel - the closest regulatory comparables to K843712.
NOMAD TM-3400
K850109 · Tracor Northern, Inc. · Jun 1985
EVOMATIC 8000/4000
K843815 · Dantec Electronics, Inc. · May 1985
QUANTUM 84
K844707 · Cadwell Laboratories, Inc. · May 1985
EVOKED POTENTIAL SYS
K842543 · Bio-Logic Systems Corp. · Nov 1984
EMG/NCV & EVOKED RESPONSE, DESIGN W/
K843253 · Neurodiagnostics, Inc. · Nov 1984
SIEGEN NEUROSCOPE
K843464 · Siegen Corp. · Nov 1984